Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Resource centre
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Claudia Martínez to share expertise on local manufacturing at USAID workshop

Access to Medicine Foundation Research Programme Manager, Claudia Martínez, will share insights on the strengthening of local manufacturing in low- and middle-income countries (LMICs) during the United States Agency for International Development (USAID)'s virtual workshop.

Date

16 October 2023

Date

16 October 2023

Format

Virtual

Claudia Martínez, Research Programme Manager for the Generic and Biosimilar Medicines Programme, will bring her expertise to USAID’s virtual workshop, exploring strategies to enhance local manufacturing in LMICs. Claudia will focus on insights from the Foundation’s upcoming report, Generic & Biosimilar Medicines Programme 2023: Company Profiles, scheduled for publication on 26 September 2023. 

This report includes tailored Company Profiles of five leading manufacturers of generic and biosimilar medicines, accompanied by a dedicated section highlighting key findings that have emerged across these companies. Claudia will spotlight these key findings, particularly focusing on stand-out examples related to both the strengthening of local manufacturing and areas for improvement. Her insights will outline actionable steps for companies and stakeholders to harness the potential of local manufacturing, thereby improving local production and ensuring the availability and accessibility of essential medicines in LMICs. 

Sectors & Research

Learn more about our Generic & Biosimilar Medicines Programme
Featured News

First-of-its-kind framework to assess how generics manufacturers expand access to medicine

15 February 2023
Event

Joint event with World Economic Forum on the evolving role of generics – Meeting Report

21 June 2023

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved